Dartora, Vanessa Franco Carvalho 
; Salata, Giovanna Cassone ; Matos, Jenyffer Kelly Rocha de ; Fernandez, Sandra Costa; Chorilli, Marlus ; Steiner, Alexandre Alarcon ; Araujo, Gabriel Lima Barros de ; Silveira, Edilberto Rocha ; Costa-Lotufo, Letícia Veras ; Lopes, Luciana Biagini
Fonte: International Journal of Pharmaceutics. Unidades: ICB, FCF
Assuntos: FARMACOLOGIA, IMUNOLOGIA, NEOPLASIAS MAMÁRIAS, CITOTOXICIDADE IMUNOLÓGICA, QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARTORA, Vanessa Franco Carvalho et al. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, v. 567, p. 13 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2019.118460. Acesso em: 16 nov. 2025.APA
Dartora, V. F. C., Salata, G. C., Matos, J. K. R. de, Fernandez, S. C., Chorilli, M., Steiner, A. A., et al. (2019). Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, 567, 13 . doi:10.1016/j.ijpharm.2019.118460NLM
Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Costa-Lotufo LV, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460Vancouver
Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Costa-Lotufo LV, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460
